Profound Medical Corp. (TSX:PRN)
Canada · Delayed Price · Currency is CAD 9.50
+0.05 (0.53%)
Sep 2, 2026, 10:55 AM EST
Profound Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 19.09 | 16.1 | 10.68 | 7.2 | 6.68 | 6.87 |
Revenue Growth | 61.20% | 50.73% | 48.35% | 7.75% | -2.79% | -5.90% |
Gross Profit Gross Profit Growth | 13.7 | 11.39 | 7.04 | 4.31 | 3.02 | 2.95 |
Operating Income Operating Income Growth | -35.37 | -41.25 | -33.06 | -28.65 | -29.6 | -30.29 |
Net Income Net Income Growth | -32.74 | -42.57 | -27.82 | -28.32 | -28.67 | -30.7 |
Earnings Per Share EPS Growth | -0.98 | -1.41 | -1.12 | -1.34 | -1.38 | -1.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 6.26 | 3.08 | 2.44 | 0.23 | 1.49 | 2.08 |
Germany Germany Growth | 0.74 | 0.77 | 0.89 | 1.84 | 1.8 | 2.71 |
United States of America (USA) United States of America (USA) Growth | 12.09 | 12.25 | 7.35 | 5.13 | 3.4 | 2.09 |
Total Total Growth | 19.09 | 16.1 | 10.68 | 7.2 | 6.68 | 6.87 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 38.27 | 59.72 | 54.91 | 26.21 | 46.52 | 67.15 |
Total Debt Total Debt Growth | 7.38 | 4.71 | 5.12 | 7.87 | 8.23 | 1.38 |
Net Cash (Debt) Net Cash Growth | 30.89 | 55.01 | 49.79 | 18.35 | 38.29 | 65.78 |
Net Cash Growth | 1.68% | 10.48% | 171.40% | -52.08% | -41.79% | -20.02% |
Net Cash Per Share Net Cash Per Share Growth | 0.93 | 1.82 | 2.01 | 0.87 | 1.84 | 3.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -36.1 | -38.21 | -23.45 | -22.61 | -25.8 | -22.36 |
Capital Expenditures CapEx Growth | -0.18 | -0.18 | - | - | - | -0.03 |
Free Cash Flow Free Cash Flow Growth | -36.28 | -38.38 | -23.45 | -22.61 | -25.8 | -22.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.79% | 70.77% | 65.89% | 59.90% | 45.22% | 42.95% |
Operating Margin | -185.31% | -256.27% | -309.57% | -397.99% | -443.08% | -440.73% |
Pretax Margin | -170.37% | -262.88% | -260.47% | -395.21% | -424.82% | -445.13% |
Profit Margin | -171.56% | -264.44% | -260.45% | -393.43% | -429.11% | -446.66% |
FCF Margin | -190.07% | -238.43% | -219.60% | -314.06% | -386.17% | -325.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 12.74 | 17.71 | 21.10 | 28.06 | 33.43 | 34.05 |